Fresenius Kabi Announces $100,000 Award to Advance Research in Therapeutic Apheresis & Cell Therapy

19-11-2013 Business Wire HealthComments (0)

Fresenius KabiPharmaceutical

Fresenius Kabi announced today it is seeking applicants for a new $100,000 U.S. research award to support the advancement of photopheresis and red cell exchange – two therapeutic areas with great promise for patient care. “Fresenius Kabi along with its Fenwal subsidiary are committed to supporting innovative science that provides hope through the advancement of photopheresis and red cell exchange,” said William Cork, executive vice president and chief technol

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top